Dr. Robert N. Abood, M.D.
Pediatrics (Pediatrics Physician)
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
OH license 35.132884 · PA license MD454163
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Children's Hospital Medical Center of Akron (141 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 16 companies reported 41 payments worth $910 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $172 |
|---|---|
| Electromed, Inc. | $139 |
| Vertex Pharmaceuticals Incorporated | $86.31 |
| Philips North America LLC | $77.23 |
| Baxter Healthcare | $76.03 |
| Viatris Specialty LLC | $57.86 |
| Amgen Inc. | $57.25 |
| Digestive Care, Inc. | $53.10 |
| Food and Beverage | $771 |
|---|---|
| Education | $139 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Jul 24, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $94.66 |
| Viatris Specialty LLC May 7, 2025 | Education | $44.18 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $27,844 in research payments for these studies, mostly to the institutions running them.
- A Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis Less Than 12 Months of Age
Vertex Pharmaceuticals Incorporated - A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.